Non-alcoholic fatty liver disease (NAFLD), specifically its progressive form non-alcoholic
steatohepatitis (NASH), represents the fastest growing indication for liver transplantation in …

In the changing landscape of liver transplantation (LT), we are now evaluating older and
sicker patients with more cardiovascular comorbidities, and the spectrum of cardiovascular …

Liver transplantation represents the only curative option for patients with end-stage liver
disease, fulminant hepatitis and advanced hepatocellular carcinoma. Even though major …

Coronary artery disease (CAD) confers increased perioperative risk in patients undergoing
liver transplantation (LT). Although routine screening for CAD is recommended, there are …

Results Of 116 LT programs surveyed, 61 (53%) programs responded across all 11 United
Network for Organ Sharing (UNOS) regions. Respondents from the programs included the …

Cardiac evaluation of liver and kidney transplant candidates requires a global assessment
for both short and long-term risk for cardiac events. Imaging of cardiac structure and function …

Introduction Recommendations on non-invasive imaging to assess pre-operative cardiac
risk among liver transplant candidates vary amongst societal guidelines and individual …

Hu et al. reported on the functional mechanisms, likely tumorigenesis-promoting
mechanisms, and the potential clinical applications related to the circular RNA (circRNA) …

Orthotopic liver transplantation (OLT) is a viable treatment option for end-stage liver disease.
Significant perioperative stress is placed on the cardiovascular system because of …

Along with the obesity epidemic there has been a major increase in non-alcoholic fatty liver
disease (NAFLD) prevalence, paralleling a steady increase in cirrhosis of the liver and …